A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lym...
Comprehensive, easy-to-understand information about this condition
How we create this content →Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
The documentation surrounding lymphoma is limited due to its complex nature and the variability in clinical presentations. Lymphoma affects a diverse population, and the lack of a well-defined genetic basis or systematic studies contributes to this challenge. Additionally, the overlapping clinical features with other hematologic conditions make precise characterization difficult.
To navigate your journey with lymphoma, consider seeking a hematologist or oncologist with expertise in lymphoid malignancies. The Leukemia & Lymphoma Society, Lymphoma Canada, and the Lymphoma Research Foundation are valuable resources that offer support and information. Additionally, you may want to explore participation in clinical trials, which can provide access to cutting-edge therapies. For genetic counseling, you can visit the National Society of Genetic Counselors at findageneticcounselor.com for help finding a specialist.
There are currently 3015 active clinical trials related to lymphoma, indicating ongoing research efforts to better understand and treat this condition. You can explore these trials through the ClinicalTrials.gov search link: https://clinicaltrials.gov/search?cond=lymphoma. While there are no orphan drug designations, the extensive research landscape provides hope for future treatment advancements.
Actionable guidance for navigating care for lymphoma
To navigate your journey with lymphoma, consider seeking a hematologist or oncologist with expertise in lymphoid malignancies. The Leukemia & Lymphoma Society, Lymphoma Canada, and the Lymphoma Research Foundation are valuable resources that offer support and information. Additionally, you may want to explore participation in clinical trials, which can provide access to cutting-edge therapies. For genetic counseling, you can visit the National Society of Genetic Counselors at findageneticcounselor.com for help finding a specialist.
Consider asking your healthcare providers these condition-specific questions
Connect with organizations supporting the lymphoma community
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.